Under construction – not a live service
Sign in

2022-502164-20-01RecruitingPhase 4

Semaglutide 2.4mg for low responders after bariatric surgery

Source: EU CTIS (euclinicaltrials.eu) · Last updated 6 Mar 2025 · Not updated for over 12 months - ask the site whether it is still open

Next steps

Brief summary (registry, in English)

To study the weight change from 3 to 18 months after surgery (% total weight loss, TWL) in low responders after bariatric surgery who are treated with Semaglutide 2.4 mg and a lifestyle intervention and compare change in weight to patients receiving placebo and a lifestyle intervention.

Status (registry)
Recruiting
Phase (registry)
Phase 4
Study type
Interventional
Enrollment
152 (estimated)
First submitted
15 Nov 2023
Start date
11 Mar 2025
Lead sponsor
Stichting Zuyderland Medisch Centrum
Diseases
Obesity
EU CT number
2022-502164-20-01

What you commit to

  • Study type: Interventional · Phase 4
  • Planned participants: 152
  • 3 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.

Who cannot take part

Copied verbatim from EU CTIS (euclinicaltrials.eu) and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Type 1 or type 2 diabetes
  • Liver failure (all)
  • Congestive heart failure or angina pectoris NYHA class III and IV
  • Malignancy in history
  • Inflammatory Bowel Disease
  • Thyroid malignancy in history

Lab values

  • Decreased renal function (creatinine clearance < 30 ml/min)

Other

  • Use of warfarin or other coumarin derivates
  • Pancreatitis (in history)
  • Pregnancy / breast-feeding

Who the study is looking for

  • Patient is ≥18 and <75 years old
  • BMI before surgery was ≥ 35.0 kg/m2
  • Patient is treated with group consultation at the Dutch Obesity Clinic (DOC)
  • Patient has undergone a primary (banded) RYGB or (banded) sleeve gastrectomy (SG)
  • Patient is in the lowest %TWL quartile, 3 months after surgery and will be enrolled in the plus module.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on EU CTIS (euclinicaltrials.eu)

Sites (3)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Rode Kruis Ziekenhuis B.V.BeverwijkNetherlandsRecruiting
Zuyderland Medisch Centrum StichtingHeerlenNetherlandsRecruiting
Sint Antonius Ziekenhuis StichtingNieuwegeinNetherlandsRecruiting

Are you the coordinator? Confirm the details

This page is information, not medical advice. Discuss any trial with your doctor.